Zhejiang Xianju Pharmaceutical Co Ltd (002332) — Cash Flow Reinvestment Rate
Zhejiang Xianju Pharmaceutical Co Ltd (002332) has a Cash Flow Reinvestment Rate of 0.23x as of September 2025, reinvesting CN¥30.01 Million (capex CN¥30.01 Million ) from operating cash flow of CN¥130.05 Million. Explore Zhejiang Xianju Pharmaceutical Co Ltd capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Zhejiang Xianju Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2006–2025)
Historical reinvestment intensity for Zhejiang Xianju Pharmaceutical Co Ltd across 20 annual periods. Also explore 002332 asset base for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Zhejiang Xianju Pharmaceutical Co Ltd (2006–2025)
Year-by-year capital reinvestment analysis for Zhejiang Xianju Pharmaceutical Co Ltd. For live market cap and broader valuation context, see Zhejiang Xianju Pharmaceutical Co Ltd (002332) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.85x | CN¥210.78 Million | CN¥247.48 Million | CN¥209.07 Million | ▲ +49.1% |
| 2024 | 0.57x | CN¥227.68 Million | CN¥398.66 Million | CN¥207.59 Million | ▼ -21.1% |
| 2023 | 0.72x | CN¥431.26 Million | CN¥595.48 Million | CN¥234.63 Million | ▼ -31.1% |
| 2022 | 1.05x | CN¥640.61 Million | CN¥609.28 Million | CN¥282.54 Million | ▲ +160.0% |
| 2021 | 0.40x | CN¥273.38 Million | CN¥676.15 Million | CN¥266.84 Million | ▼ -46.5% |
| 2020 | 0.76x | CN¥596.55 Million | CN¥789.23 Million | CN¥118.17 Million | ▲ +32.7% |
| 2019 | 0.57x | CN¥296.18 Million | CN¥519.81 Million | CN¥262.34 Million | ▼ -61.7% |
| 2018 | 1.49x | CN¥287.70 Million | CN¥193.27 Million | CN¥169.26 Million | ▼ -1.5% |
| 2017 | 1.51x | CN¥253.16 Million | CN¥167.47 Million | CN¥123.28 Million | ▲ +77.1% |
| 2016 | 0.85x | CN¥133.11 Million | CN¥155.91 Million | CN¥97.10 Million | ▼ -65.9% |
| 2015 | 2.50x | CN¥499.17 Million | CN¥199.61 Million | CN¥115.05 Million | ▲ +227.2% |
| 2014 | 0.76x | CN¥108.26 Million | CN¥141.64 Million | CN¥108.26 Million | ▼ -74.4% |
| 2013 | 2.98x | CN¥189.26 Million | CN¥63.46 Million | CN¥189.26 Million | ▼ -66.5% |
| 2012 | 8.91x | CN¥298.01 Million | CN¥33.43 Million | CN¥298.01 Million | ▲ +380.1% |
| 2011 | 1.86x | CN¥274.14 Million | CN¥147.63 Million | CN¥274.14 Million | ▲ +360.8% |
| 2010 | 0.40x | CN¥62.58 Million | CN¥155.29 Million | CN¥62.58 Million | ▼ -1.8% |
| 2009 | 0.41x | CN¥42.94 Million | CN¥104.68 Million | CN¥42.94 Million | ▼ -75.1% |
| 2008 | 1.64x | CN¥59.25 Million | CN¥36.03 Million | CN¥59.25 Million | ▲ +135.0% |
| 2007 | 0.70x | CN¥67.55 Million | CN¥96.53 Million | CN¥67.55 Million | ▲ +1.7% |
| 2006 | 0.69x | CN¥36.51 Million | CN¥53.05 Million | CN¥36.51 Million | — |